Medical Solutions expands genomics offerings with Autogen buy
This article was originally published in Clinica
Executive Summary
In a move to expand its molecular diagnostics business, UK Medical Solutions has conditionally agreed to acquire Autogen Bioclear in an all-cash deal worth up to £6m ($12m). Calne, Wiltshire-based Autogen distributes diagnostic kits, antibodies, DNA clones and other products for genetic testing to the academic and charitably-funded research sectors. The company, which has nine employees, posted a turnover of £2.7m (+10%) for fiscal 2007, while pre-tax profits were up 47% at £823,000. Medical Solutions, based in Nottingham, said the acquisition would present cross-selling opportunities and cost savings, among other benefits.
You may also be interested in...
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.